ClinicalTrials.gg
Not yet recruitingNCT07869849UMPMR-VUpdated Oct 13, 2026

A Minute for my Kidneys

An interventional study of Dialysis in Chronic Kidney Diseases, sponsored by GCS Ramsay Santé pour l'Enseignement et la Recherche. Not yet recruiting at 1 site in France. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-10-13.

Sponsored by GCS Ramsay Santé pour l'Enseignement et la Recherche · Not applicable, Interventional, and Other

Updated Oct 13, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
312
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The purpose of this study is to evaluate the effectiveness of the "One Minute for My Kidneys" program in reducing the time it takes for participants with stage V chronic kidney disease and other comorbidities to begin dialysis.

Read the detailed description

This is a multicenter, interventional, prospective, randomized, controlled, open-label clinical investigation.

The study population is composed of adults with stage V chronic kidney disease and other comorbidities.

Participants are offered enrollment in the clinical trial during a nephrology follow-up visit for their chronic kidney disease. Participants who are enrolled after signing an informed consent form and confirming their eligibility will then be randomized to either the group receiving access to the "1 Minute for My Kidneys" program in addition to standard of care, or the group receiving standard of care alone.

02

Conditions studied

  • Chronic Kidney Diseases
03

In context

Renal Insufficiency, Chronic

3,224 studies on the registry are indexed under Renal Insufficiency, Chronic; 706 are open to participants now.

This study's planned enrollment of 312 is above the median of 74 across 2,229 interventional studies indexed under Renal Insufficiency, Chronic.

Browse Renal Insufficiency, Chronic studies →

Lead sponsor

GCS Ramsay Santé pour l'Enseignement et la Recherche is the lead sponsor of 204 studies on the registry; 97 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥ 18 and ≤ 80;
  • Participants with stage V chronic kidney disease;
  • Participants with documented type 2 diabetes AND/OR documented glomerular disease (proteinuria > 1 g/24 h) AND/OR diagnosed with heart failure as recognized by a cardiologist according to the criteria of the European Society of Cardiology;
  • Participants who have and agree to use an internet connection;
  • Participants who speak and understand French and are able to complete the questionnaires;
  • Participants who have been informed and have signed an informed consent form;
  • Participants covered by a social security program.

Exclusion criteria

Exclusion Criteria:

  • Inability to use the app (blindness, severe intellectual disability);
  • Life expectancy of less than 6 months, as determined by the investigator;
  • Significant noncompliance, as determined by the investigator;
  • Participants for whom, in the event of end-stage renal disease, palliative care would be chosen over dialysis or transplantation;
  • Women who are pregnant or may become pregnant (of childbearing age and not using effective contraception) or who are breastfeeding;
  • Persons under legal guardianship (under legal protection or deprived of liberty by judicial or administrative decision);
  • A person unable to understand the information related to the study (due to linguistic, psychological, cognitive, or other reasons);
  • A participant currently enrolled in another clinical trial or study, or who has participated in another clinical trial or study that could have affected their health status within the 6 months prior to enrollment.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
312 participants (estimated)

Study arms

  • Experimental
    "1 Minute for My Kidneys" App

    Participants in the experimental group will be monitored, in addition to receiving standard care, using the "1 Minute for My Kidneys" app. In addition, they will be required to complete a quality-of-life questionnaire (EQ-5D-5L, available directly in the app) once every 3 months.

    Drug: Dialysis

  • Active comparator
    Control group with quality of life

    In addition to their usual care, participants in the control group will be asked to complete a questionnaire on quality of life during their nephrology appointment once every three months.

    Drug: Dialysis

Interventions

  • DrugDialysis

    Dialysis for a patient with stage V chronic kidney disease

06

What researchers measure

Primary outcomes

  1. Time to initiation of dialysis

    Time to initiation of dialysis (scheduled and unscheduled) for participants with stage V chronic kidney disease and one or more comorbidities.

    Time frame: Up to 24 months

07

Study locations

1 site
08

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 13, 2026
Show all 1 update
  1. Oct 13, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07869849
Collaborators
Euraxi Pharma
Responsible party
Sponsor
First posted
Oct 13, 2026
Start date
Nov 2026 (estimated)
Primary completion
Dec 2029 (estimated)
Completion
Dec 2029 (estimated)
Last update
Oct 13, 2026

Study contacts

Maxime HOFFMANN, MD
Contact
maxime.hoffmann@gmail.com
6 86 70 91 23 ext. +33
Maxime HOFFMANN
principal investigator · Hôpital Privé La Louvière

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion